3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pain, Postoperative
9
Breast Neoplasms
6
Brain Neoplasms
6
Neoplasms
4
Lung Neoplasms
4
Thyroid Neoplasms
3
Agnosia
3
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Rectal Neoplasms
2
Prostatic Neoplasms
2
Pheochromocytoma
2
Neoplasm Metastasis
2
Liver Neoplasms
2
Dexmedetomidine
2
Colonic Neoplasms
2
Chronic Pain
2
Supratentorial Neoplasms
1
Sleep Initiation and Maintenance Disorders
1
Sigmoid Neoplasms
1
Seizures
1
Prostatic Hyperplasia
1
Postoperative Nausea and Vomiting
1
Postoperative Analgesia
1
Pneumoperitoneum
1
Pancreatic Neoplasms
1
Pain, Intractable
1
Obesity
1
Neuroinflammatory Diseases
1
Neurofibromatoses
1
Interventions
Sodium Chloride
1
Dexmedetomidine
1
Cefpirome
1
Adalimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Abscess
×
Dexmedetomidine
×
Clear all
NCT04932746
2023-02-17
RCT
Damascus University
Phase NA
Completed
110 enrolled